BMRN fundamentals
BIOMARIN PHARMACEUTICAL INC revenue breakdown overview
BIOMARIN PHARMACEUTICAL INC revenue for the last year amounted to 2.76 B EUR, the most of which — 2.76 B EUR — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 2.19 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought BIOMARIN PHARMACEUTICAL INC 893.35 M EUR, and the year before that — 698.82 M EUR.
By source
2017
2018
2019
2020
2021
2022
2023
2024
0.00
700.00 M
1.40 B
2.10 B
2.80 B
Innovative Therapies
Currency: EUR
2017
2018
2019
2020
2021
2022
2023
2024
Innovative Therapies
1.52 B
1.62 B
1.96 B
2.19 B
2.76 B
By country
2017
2018
2019
2020
2021
2022
2023
2024
0.00
700.00 M
1.40 B
2.10 B
2.80 B
United States
Europe
Rest of World
Latin America
Global
Currency: EUR
2017
2018
2019
2020
2021
2022
2023
2024
United States
745.68 M
578.64 M
639.37 M
698.82 M
893.35 M
Europe
423.74 M
491.76 M
608.22 M
606.42 M
800.83 M
Rest of World
182.87 M
222.52 M
291.12 M
424.20 M
476.84 M
Latin America
168.25 M
168.17 M
249.29 M
301.19 M
365.22 M
Global
—
163.24 M
170.46 M
161.21 M
177.63 M